Neurologix, Inc.

68 articles about Neurologix, Inc.

• Neurologix, Inc. Retains MTS Health Partners, L.P. as Strategic Advisor

  2/12/2010

• Neurologix, Inc. Gains Broadened U.S. Patent Protection for Its GAD-Based Gene Delivery System

  1/26/2010

• Neurologix, Inc. Completes All Surgical Procedures in Its Clinical Trial for Parkinson's Disease

  12/3/2009

• Neurologix, Inc. Announces Third Quarter 2009 Financial Results

  11/12/2009

• Neurologix, Inc. to Showcase Novel Brain and CNS Disease Gene Therapies at BioPharm America

  9/14/2009

• Neurologix, Inc. to Present at Rodman & Renshaw 11th Annual Healthcare Conference

  9/3/2009

• Neurologix, Inc. Announces Second Quarter 2009 Financial Results

  8/12/2009

• Neurologix, Inc. Announces Q1 2009 Financial Results

  5/12/2009

• Neurologix, Inc. to Present at The Neurotech Industry Investing and Partnering Conference 2009

  5/7/2009

• Neurologix, Inc. Announces Year End 2008 Results

  3/26/2009

• Neurologix, Inc. Commences its Phase 2 Clinical Trial of Novel Gene Transfer Approach for Treatment of Parkinson’s Disease

  1/21/2009

• Neurologix, Inc. Announces Third Quarter 2008 Financial Results

  11/14/2008

• Neurologix, Inc. Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease

  9/3/2008

• Diamyd Medical AB’s Licensee Reports Progress with GAD in Parkinson

  8/20/2008

• Neurologix, Inc. Initiates Recruitment for Phase 2 Parkinson's Disease Trial

  8/19/2008

• Neurologix, Inc. Announces Second Quarter 2008 Financial Results

  8/12/2008

• Neurologix, Inc. to Present at Collins Stewart Fourth Annual Growth Conference

  7/7/2008

• Neurologix, Inc. Announces First Quarter 2008 Financial Results

  5/13/2008

• Neurologix, Inc. Completes Additional $5 Million Private Placement

  4/29/2008

• Neurologix, Inc. Receives FDA Clearance to Initiate Phase 2 Trial in Parkinson's Disease Subjects

  3/27/2008